Edward Karpman, MD
Urology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 8 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
31 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Karpman’s office at (650) 962-4321 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Aetna Medicare Enhanced (HMO-POS) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced Extra (HMO-POS) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A73115 · Current
Licensed to practise in California · since 2000 · expires 2028-03-31 · University of Vermont College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$734,198
Medicare paid this office $734,198 for 594 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, testosterone undecanoate, 1 mg | 46 | $191,554 | None |
| Return visit (30+ min) | 485 | $110,429 | $111 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 156 | $71,314 | $377 |
| Long return visit (40+ min) | 236 | $55,218 | $168 |
| Diagnostic exam of bladder and urethra using an endoscope | 93 | $24,878 | $239 |
See all 31 services
| Injection, testosterone undecanoate, 1 mg | 46 | $191,554 | None |
| Return visit (30+ min) | 485 | $110,429 | $111 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 156 | $71,314 | $377 |
| Long return visit (40+ min) | 236 | $55,218 | $168 |
| Diagnostic exam of bladder and urethra using an endoscope | 93 | $24,878 | $239 |
| Unclassified drugs | 53 | $21,686 | None |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 29 | $19,898 | $686 |
| Insertion of multicomponent inflatable penile implant | 23 | $16,171 | $703 |
| New patient visit (60+ min) | 71 | $13,923 | $196 |
| Ultrasound scan of pelvic region through rectum | 75 | $11,110 | $144 |
| Placement of hormone pellet under skin | 48 | $10,616 | $91 |
| Ultrasound measurement of bladder capacity after voiding | 435 | $9,587 | $11 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 344 | $7,719 | $15 |
| Complete ultrasound of penis artery and vein blood flow | 44 | $5,069 | $115 |
| Injection of drug or substance under skin or into muscle | 73 | $4,169 | $13 |
| Complete ultrasound scan behind abdominal cavity | 37 | $4,032 | $103 |
| Injection procedure to cause erection | 34 | $3,060 | $85 |
| Ultrasound of penis artery and vein blood flow | 35 | $2,601 | $74 |
| New patient visit (45+ min) | 22 | $2,595 | $118 |
| Short return visit (20+ min) | 31 | $2,591 | $76 |
| Biopsy of prostate gland | 17 | $1,942 | $114 |
| Limited ultrasound scan of pelvis | 36 | $1,647 | $43 |
| Electronic assessment of bladder emptying | 153 | $1,317 | $7 |
| Simple bladder irrigation and/or instillation | 14 | $1,193 | $75 |
| Ultrasound scan of pelvic region through rectum | 39 | $1,172 | $29 |
| Injection procedure to cause erection | 23 | $785 | $34 |
| Injection, phentolamine mesylate, up to 5 mg | 17 | $540 | None |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $463 | $24 |
| Injection, testosterone cypionate, 1 mg | 17 | $399 | None |
| Urinalysis, manual test | 56 | $239 | $3 |
| Manual urinalysis test with examination using microscope, automated | 35 | $121 | $3 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Prostate resection | 21 | More than 81% of doctors who do this |
Who their Medicare patients are
594 Original Medicare patients in 2024. Average age 76 · Under 65 2% · 85 and older 16% · Also on Medicaid 9% · Health risk score 1.12. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Coronary heart disease 43% · Diabetes 31% · Cancer 30% · Chronic kidney disease 28% · Atrial fibrillation 26% · Heart failure 13% · COPD 10% · Depression 10% · Stroke 10% · Dementia 7%.
The office billed $2,899,077, Medicare allowed $944,658 and paid $734,198; for 160,964 services of 95 kinds; $287,228 of it was for drugs given in the office and $446,970 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 594 | 160,964 | 76 | 1.12 | $2,899,077 | $734,198 |
| 2023 | 571 | 181,488 | 77 | 1.05 | $1,519,365 | $702,294 |
| 2022 | 553 | 165,720 | 76 | 1.04 | $1,389,411 | $616,828 |
| 2021 | 560 | 177,453 | 76 | 1.05 | $1,382,591 | $628,624 |
| 2020 | 531 | 181,953 | 76 | 1.10 | $1,265,938 | $528,208 |
| 2019 | 593 | 216,787 | 76 | 1.16 | $1,544,919 | $627,032 |
| 2018 | 595 | 209,153 | 76 | 1.16 | $1,290,185 | $553,429 |
| 2017 | 548 | 210,248 | 76 | 1.18 | $1,209,622 | $534,882 |
| 2016 | 528 | 181,644 | 75 | 1.11 | $1,263,023 | $506,494 |
| 2015 | 546 | 168,546 | 76 | 1.07 | $1,415,815 | $552,158 |
| 2014 | 516 | 5,949 | 76 | 1.00 | $1,034,183 | $412,515 |
| 2013 | 519 | 5,433 | 76 | 1.07 | $1,037,659 | $405,062 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Injection, testosterone undecanoate, 1 mg | 46 | $200,958 | None |
| Return visit (30+ min) | 528 | $130,783 | $111 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 162 | $76,230 | $383 |
| Unclassified drugs | 48 | $54,586 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 104 | $27,705 | $223 |
| Insertion of multicomponent inflatable penile implant | 32 | $22,553 | $705 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 20 | $14,912 | $746 |
| New patient visit (45+ min) | 111 | $14,607 | $132 |
| Placement of hormone pellet under skin | 48 | $10,073 | $92 |
| Ultrasound measurement of bladder capacity after voiding | 432 | $9,636 | $11 |
| Ultrasound scan of pelvic region through rectum | 58 | $8,629 | $146 |
| Removal and replacement of multicomponent inflatable penile implant during same surgery | 11 | $8,166 | $742 |
| Injection of drug or substance under skin or into muscle | 67 | $4,934 | $13 |
| Complete ultrasound scan behind abdominal cavity | 31 | $4,244 | $115 |
| Complete ultrasound of penis artery and vein blood flow | 36 | $4,243 | $118 |
| Short return visit (20+ min) | 46 | $4,096 | $79 |
| Limited ultrasound scan of pelvis | 33 | $1,812 | $46 |
| Electronic assessment of bladder emptying | 188 | $1,785 | $7 |
| Injection procedure to cause erection | 24 | $1,759 | $73 |
| Biopsy of prostate gland | 13 | $1,428 | $110 |
| Injection procedure to cause erection | 32 | $1,072 | $34 |
| Ultrasound scan of pelvic region through rectum | 31 | $998 | $29 |
| Ultrasonic guidance for needle placement | 14 | $816 | $58 |
| Manual urinalysis test with examination using microscope, automated | 191 | $796 | $3 |
| Injection, testosterone cypionate, 1 mg | 14 | $760 | None |
| Ultrasonic guidance for needle placement | 11 | $325 | $27 |
2022: 23 services
| Injection, testosterone undecanoate, 1 mg | 45 | $164,301 | None |
| Return visit (30+ min) | 517 | $125,652 | $111 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 138 | $68,617 | $392 |
| Unclassified drugs | 42 | $54,082 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 83 | $22,005 | $212 |
| Insertion of multicomponent inflatable penile implant | 26 | $18,201 | $700 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 22 | $16,100 | $732 |
| New patient visit (45+ min) | 79 | $11,025 | $140 |
| Placement of hormone pellet under skin | 42 | $9,409 | $90 |
| Short return visit (20+ min) | 32 | $7,514 | $84 |
| Ultrasound measurement of bladder capacity after voiding | 354 | $6,087 | $11 |
| Ultrasound scan of pelvic region through rectum | 39 | $5,886 | $151 |
| Complete ultrasound scan behind abdominal cavity | 41 | $5,708 | $116 |
| Injection of drug or substance under skin or into muscle | 69 | $4,660 | $13 |
| Complete ultrasound scan of pelvis | 35 | $4,490 | $110 |
| Complete ultrasound of penis artery and vein blood flow | 33 | $3,916 | $115 |
| Injection procedure to cause erection | 36 | $2,937 | $77 |
| Electronic assessment of bladder emptying | 146 | $1,264 | $7 |
| Injection procedure to cause erection | 26 | $875 | $34 |
| Ultrasound scan of pelvic region through rectum | 27 | $839 | $30 |
| Manual urinalysis test with examination using microscope, automated | 196 | $743 | $3 |
| Injection, testosterone cypionate, 1 mg | 16 | $730 | None |
| Imaging of urinary tract following injection of a contrast agent | 11 | $338 | $23 |
2021: 23 services
| Injection, testosterone undecanoate, 1 mg | 46 | $166,091 | None |
| Return visit (30+ min) | 519 | $131,994 | $115 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 130 | $66,067 | $396 |
| Unclassified drugs | 40 | $57,452 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 90 | $22,454 | $200 |
| Insertion of multicomponent inflatable penile implant | 23 | $15,847 | $689 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 17 | $12,764 | $751 |
| New patient visit (45+ min) | 82 | $11,646 | $142 |
| Placement of hormone pellet under skin | 40 | $10,183 | $94 |
| Ultrasound scan of pelvic region through rectum | 56 | $8,998 | $150 |
| Short return visit (20+ min) | 16 | $8,131 | $87 |
| Ultrasound measurement of bladder capacity after voiding | 388 | $6,875 | $11 |
| Injection of drug or substance under skin or into muscle | 78 | $5,329 | $14 |
| Complete ultrasound scan behind abdominal cavity | 36 | $4,763 | $116 |
| Complete ultrasound scan of pelvis | 35 | $4,470 | $112 |
| Complete ultrasound of penis artery and vein blood flow | 32 | $4,101 | $124 |
| Injection procedure to cause erection | 32 | $2,867 | $82 |
| Long return visit (40+ min) | 13 | $2,316 | $165 |
| Electronic assessment of bladder emptying | 143 | $1,612 | $9 |
| Manual urinalysis test with examination using microscope, automated | 239 | $1,009 | $3 |
| Injection, testosterone cypionate, 1 mg | 23 | $965 | None |
| Injection procedure to cause erection | 23 | $788 | $34 |
| Ultrasound scan of pelvic region through rectum | 21 | $643 | $31 |
2020: 25 services
| Injection, testosterone undecanoate, 1 mg | 50 | $164,287 | None |
| Return visit (30+ min) | 488 | $102,687 | $94 |
| Unclassified drugs | 35 | $51,792 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 116 | $48,654 | $360 |
| Diagnostic exam of bladder and urethra using an endoscope | 80 | $17,933 | $183 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 19 | $14,246 | $750 |
| Insertion of multicomponent inflatable penile implant | 19 | $12,512 | $659 |
| New patient visit (45+ min) | 68 | $9,176 | $135 |
| Placement of hormone pellet under skin | 35 | $9,014 | $92 |
| Removal and replacement of multicomponent inflatable penile implant during same surgery | 11 | $8,500 | $773 |
| Short return visit (20+ min) | 25 | $8,333 | $69 |
| Ultrasound scan of pelvic region through rectum | 51 | $8,127 | $153 |
| Ultrasound measurement of bladder capacity after voiding | 366 | $6,261 | $10 |
| Injection of drug or substance under skin or into muscle | 79 | $5,114 | $14 |
| Complete ultrasound of penis artery and vein blood flow | 33 | $4,090 | $124 |
| Long return visit (40+ min) | 22 | $3,098 | $141 |
| Complete ultrasound scan behind abdominal cavity | 25 | $3,086 | $114 |
| Injection procedure to cause erection | 33 | $2,708 | $77 |
| Complete ultrasound scan of pelvis | 23 | $2,665 | $107 |
| Electronic assessment of bladder emptying | 144 | $1,488 | $8 |
| Manual urinalysis test with examination using microscope, automated | 235 | $1,051 | $3 |
| Injection, testosterone cypionate, 1 mg | 20 | $806 | None |
| Ultrasound scan of pelvic region through rectum | 23 | $719 | $31 |
| Ultrasonic guidance for needle placement | 11 | $687 | $57 |
| Injection procedure to cause erection | 19 | $643 | $34 |
2019: 29 services
| Injection, testosterone undecanoate, 1 mg | 51 | $177,957 | None |
| Return visit (30+ min) | 547 | $126,573 | $96 |
| Unclassified drugs | 44 | $59,185 | None |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 126 | $55,680 | $344 |
| Diagnostic exam of bladder and urethra using an endoscope | 104 | $19,921 | $163 |
| Insertion of multicomponent inflatable penile implant | 27 | $19,284 | $714 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 19 | $14,443 | $760 |
| New patient visit (45+ min) | 93 | $12,299 | $132 |
| Short return visit (20+ min) | 28 | $10,938 | $65 |
| Placement of hormone pellet under skin | 44 | $10,534 | $91 |
| Ultrasound measurement of bladder capacity after voiding | 451 | $10,163 | $13 |
| Ultrasound scan of pelvic region through rectum | 69 | $10,106 | $133 |
| Injection of drug or substance under skin or into muscle | 94 | $7,579 | $16 |
| Long return visit (40+ min) | 39 | $5,787 | $135 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 12 | $4,064 | $290 |
| Complete ultrasound scan behind abdominal cavity | 30 | $4,047 | $116 |
| Complete ultrasound of penis artery and vein blood flow | 32 | $3,980 | $124 |
| Biopsy of prostate gland | 15 | $3,720 | $248 |
| Complete ultrasound scan of pelvis | 26 | $3,291 | $110 |
| Injection procedure to cause erection | 33 | $2,495 | $76 |
| Complicated insertion of bladder tube | 14 | $2,342 | $123 |
| Electronic assessment of bladder emptying | 193 | $2,324 | $8 |
| Manual urinalysis test with examination using microscope, automated | 315 | $1,577 | $3 |
| Ultrasound scan of scrotum | 12 | $1,516 | $108 |
| Injection, testosterone cypionate, 1 mg | 28 | $989 | None |
| Injection procedure to cause erection | 27 | $927 | $34 |
| Ultrasonic guidance for needle placement | 15 | $838 | $56 |
| Ultrasound scan of pelvic region through rectum | 21 | $646 | $31 |
| Injection, ceftriaxone sodium, per 250 mg | 14 | $6 | None |
2018: 26 services
| Injection, testosterone undecanoate, 1 mg | 57 | $169,277 | None |
| Return visit (30+ min) | 552 | $104,597 | $93 |
| Unclassified drugs | 42 | $61,058 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 103 | $20,086 | $162 |
| Insertion of multicomponent inflatable penile implant | 25 | $17,640 | $706 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 20 | $15,034 | $752 |
| Ultrasound measurement of bladder capacity after voiding | 457 | $13,142 | $16 |
| New patient visit (45+ min) | 88 | $12,297 | $140 |
| Placement of hormone pellet under skin | 42 | $10,978 | $89 |
| Injection of drug or substance under skin or into muscle | 101 | $9,166 | $19 |
| Short return visit (20+ min) | 49 | $5,801 | $68 |
| Ultrasound scan of pelvic region through rectum | 49 | $4,686 | $94 |
| Long return visit (40+ min) | 25 | $3,178 | $127 |
| Biopsy of prostate gland | 14 | $3,074 | $220 |
| Electronic assessment of bladder emptying | 166 | $2,789 | $12 |
| Manual urinalysis test with examination using microscope, automated | 393 | $2,450 | $4 |
| Complete ultrasound scan behind abdominal cavity | 20 | $2,360 | $112 |
| Complete ultrasound of penis artery and vein blood flow | 17 | $2,142 | $126 |
| Complete ultrasound scan of pelvis | 19 | $2,130 | $107 |
| Injection procedure to cause erection | 19 | $1,642 | $71 |
| Injection, testosterone cypionate, 1 mg | 28 | $968 | None |
| Injection procedure to cause erection | 26 | $894 | $34 |
| Simple bladder irrigation and/or instillation | 12 | $814 | $68 |
| Ultrasonic guidance for needle placement | 14 | $785 | $56 |
| Ultrasound scan of pelvic region through rectum | 25 | $741 | $30 |
| Injection, ceftriaxone sodium, per 250 mg | 15 | $6 | None |
2017: 21 services
| Injection, testosterone undecanoate, 1 mg | 54 | $169,987 | None |
| Return visit (30+ min) | 513 | $98,237 | $92 |
| Unclassified drugs | 42 | $62,536 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 96 | $19,389 | $160 |
| Insertion of multicomponent inflatable penile implant | 25 | $17,387 | $695 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 22 | $16,522 | $751 |
| Ultrasound measurement of bladder capacity after voiding | 449 | $15,779 | $19 |
| Injection of drug or substance under skin or into muscle | 84 | $11,723 | $25 |
| Placement of hormone pellet under skin | 42 | $11,383 | $88 |
| New patient visit (45+ min) | 69 | $9,149 | $133 |
| Ultrasound scan of pelvic region through rectum | 36 | $3,427 | $95 |
| Biopsy of prostate gland | 14 | $2,984 | $213 |
| Manual urinalysis test with examination using microscope, automated | 371 | $2,639 | $4 |
| Electronic assessment of bladder emptying | 137 | $2,254 | $12 |
| Long return visit (40+ min) | 15 | $1,907 | $127 |
| Ultrasound scan of pelvic region through rectum | 32 | $979 | $30 |
| Injection procedure to cause erection | 11 | $905 | $70 |
| Injection, testosterone cypionate, 1 mg | 26 | $901 | None |
| Ultrasonic guidance for needle placement | 15 | $884 | $59 |
| Injection procedure to cause erection | 25 | $853 | $34 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $681 | $19 |
2016: 29 services
| Injection, testosterone undecanoate, 1 mg | 46 | $127,112 | None |
| Return visit (30+ min) | 488 | $93,636 | $87 |
| Unclassified drugs | 40 | $57,743 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 96 | $22,716 | $186 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 11 | $16,340 | None |
| Ultrasound measurement of bladder capacity after voiding | 425 | $14,242 | $17 |
| Insertion of multicomponent inflatable penile implant | 21 | $12,342 | $588 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 16 | $11,336 | $709 |
| Placement of hormone pellet under skin | 40 | $10,708 | $86 |
| Injection of drug or substance under skin or into muscle | 71 | $9,417 | $23 |
| New patient visit (45+ min) | 63 | $8,045 | $128 |
| Ultrasound scan of pelvic region through rectum | 39 | $3,641 | $89 |
| Manual urinalysis test with examination using microscope, automated | 389 | $3,172 | $4 |
| Long return visit (40+ min) | 24 | $3,103 | $129 |
| Biopsy of prostate gland | 14 | $2,793 | $199 |
| Complete ultrasound scan behind abdominal cavity | 24 | $2,754 | $110 |
| Electronic assessment of bladder emptying | 130 | $2,267 | $12 |
| Complicated insertion of bladder tube | 12 | $1,910 | $119 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 58 | $1,451 | $17 |
| Complete ultrasound scan of pelvis | 12 | $1,282 | $107 |
| Screening test for pathogenic organisms | 110 | $1,231 | $9 |
| Injection, testosterone cypionate, 1 mg | 21 | $851 | None |
| Ultrasonic guidance for needle placement | 14 | $848 | $57 |
| Ultrasound scan of pelvic region through rectum | 26 | $758 | $29 |
| Injection procedure to cause erection | 19 | $568 | $30 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 11 | $468 | $31 |
| Bacterial colony count, urine | 22 | $334 | $11 |
| Bacterial urine culture | 21 | $280 | $9 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 21 | $276 | $9 |
2015: 33 services
| Injection, testosterone undecanoate, 1 mg | 41 | $109,388 | None |
| Return visit (30+ min) | 497 | $102,643 | $92 |
| Unclassified drugs | 46 | $61,913 | None |
| Diagnostic exam of bladder and urethra using an endoscope | 102 | $24,100 | $194 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 14 | $21,746 | None |
| Ultrasound measurement of bladder capacity after voiding | 472 | $18,895 | $19 |
| Insertion of multicomponent inflatable penile implant | 24 | $16,694 | $696 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 23 | $16,394 | $713 |
| Placement of hormone pellet under skin | 44 | $11,778 | $88 |
| New patient visit (45+ min) | 82 | $10,770 | $131 |
| Injection of drug or substance under skin or into muscle | 74 | $9,749 | $25 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 12 | $5,888 | $491 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 43 | $4,410 | $42 |
| Manual urinalysis test with examination using microscope, automated | 428 | $3,674 | $4 |
| Ultrasound scan of pelvic region through rectum | 38 | $3,605 | $90 |
| Biopsy of prostate gland | 13 | $2,697 | $207 |
| Electronic assessment of bladder emptying | 144 | $2,615 | $12 |
| Simple bladder irrigation and/or instillation | 27 | $2,411 | $75 |
| Complete ultrasound scan behind abdominal cavity | 20 | $2,400 | $114 |
| Long return visit (40+ min) | 16 | $2,068 | $129 |
| Screening test for pathogenic organisms | 164 | $2,042 | $9 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 47 | $1,909 | $19 |
| Short return visit (20+ min) | 31 | $1,859 | $60 |
| Injection procedure to cause erection | 18 | $1,493 | $79 |
| Complete ultrasound of penis artery and vein blood flow | 13 | $1,469 | $113 |
| Injection, testosterone cypionate, 1 mg | 29 | $943 | None |
| Ultrasonic guidance for needle placement | 13 | $814 | $58 |
| Ultrasound scan of pelvic region through rectum | 24 | $790 | $30 |
| Injection procedure to cause erection | 23 | $781 | $34 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 13 | $722 | $33 |
| Bacterial colony count, urine | 26 | $603 | $11 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 26 | $497 | $9 |
| Bacterial urine culture | 26 | $489 | $9 |
2014: 29 services
| Unclassified drugs | 73 | $126,317 | None |
| Return visit (30+ min) | 333 | $45,486 | $89 |
| Short return visit (20+ min) | 340 | $37,522 | $64 |
| Diagnostic exam of bladder and urethra using an endoscope | 94 | $21,064 | $186 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 26 | $19,042 | $732 |
| Placement of hormone pellet under skin | 64 | $17,803 | $92 |
| Ultrasound measurement of bladder capacity after voiding | 420 | $15,660 | $19 |
| Insertion of multicomponent inflatable penile implant | 14 | $9,774 | $698 |
| New patient visit (45+ min) | 68 | $8,769 | $129 |
| Injection of drug or substance under skin or into muscle | 66 | $8,621 | $24 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 64 | $8,161 | $43 |
| Ultrasound scan of pelvic region through rectum | 53 | $4,717 | $87 |
| Biopsy of prostate gland | 20 | $4,085 | $204 |
| Complicated insertion of bladder tube | 13 | $3,064 | $123 |
| Long return visit (40+ min) | 16 | $2,267 | $133 |
| Electronic assessment of bladder emptying | 136 | $2,195 | $11 |
| Manual urinalysis test with examination using microscope, automated | 297 | $2,157 | $4 |
| Simple bladder irrigation and/or instillation | 25 | $2,056 | $76 |
| Screening test for pathogenic organisms | 144 | $1,765 | $9 |
| Ultrasonic guidance for needle placement | 20 | $1,582 | $72 |
| Injection procedure to cause erection | 17 | $1,490 | $75 |
| Complete ultrasound of penis artery and vein blood flow | 15 | $1,487 | $99 |
| Complete ultrasound scan behind abdominal cavity | 11 | $1,441 | $131 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 52 | $1,427 | $18 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 40 | $1,104 | None |
| Injection procedure to cause erection | 15 | $506 | $34 |
| Bacterial colony count, urine | 27 | $399 | $11 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 27 | $350 | $9 |
| Bacterial urine culture | 27 | $333 | $9 |
2013: 28 services
| Unclassified drugs | 85 | $118,992 | None |
| Return visit (30+ min) | 439 | $82,635 | $91 |
| Diagnostic exam of bladder and urethra using an endoscope | 112 | $25,001 | $185 |
| Placement of hormone pellet under skin | 86 | $17,712 | $92 |
| Ultrasound measurement of bladder capacity after voiding | 414 | $15,606 | $20 |
| New patient visit (45+ min) | 87 | $12,069 | $139 |
| Complete laser fragmentation of prostate including control of bleeding using an endoscope | 17 | $11,982 | $705 |
| Insertion of multicomponent inflatable penile implant | 20 | $11,939 | $597 |
| Injection of drug or substance under skin or into muscle | 77 | $8,899 | $22 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 87 | $8,555 | $45 |
| Ultrasonic guidance for needle placement | 33 | $7,086 | $215 |
| Short return visit (20+ min) | 78 | $6,037 | $66 |
| Biopsy of prostate gland | 30 | $5,683 | $189 |
| Complete ultrasound of penis artery and vein blood flow | 22 | $3,322 | $151 |
| Ultrasound scan of pelvic region through rectum | 44 | $3,045 | $68 |
| Manual urinalysis test with examination using microscope, automated | 329 | $2,452 | $4 |
| Electronic assessment of bladder emptying | 145 | $2,071 | $11 |
| Screening test for pathogenic organisms | 156 | $1,897 | $9 |
| Injection procedure to cause erection | 22 | $1,709 | $78 |
| Simple bladder irrigation and/or instillation | 20 | $1,623 | $68 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 57 | $1,542 | $19 |
| Complete ultrasound scan behind abdominal cavity | 12 | $1,536 | $118 |
| Injection, testosterone cypionate, 1 cc, 200 mg | 68 | $1,520 | None |
| Injection, phentolamine mesylate, up to 5 mg | 11 | $960 | None |
| Injection procedure to cause erection | 18 | $594 | $33 |
| Bacterial colony count, urine | 21 | $383 | $11 |
| Bacterial urine culture | 21 | $311 | $9 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | 21 | $309 | $9 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 12 | $0 |
| 2024 | 12 | 1 | 12 | $0 |
| 2023 | 27 | 2 | 13 | $207 |
| 2021 | 48 | 1 | 17 | $0 |
| 2020 | 16 | 1 | 15 | $0 |
| 2019 | 41 | 2 | 15 | $111 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 14 | $201 |
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 13 | $6 |
2021
| Return visit (30+ min) | 48 | $0 |
2020
| Return visit (30+ min) | 16 | $0 |
2019
| Measurement of post-voiding residual urine and/or bladder capacity by ultrasound, non-imaging | 13 | $111 |
| Return visit (30+ min) | 28 | $0 |
Drugs they prescribed that Part D paid
$158,175
Pharmacies billed $158,175 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
885 generic and 132 brand-name prescriptions · $158,175 in drug cost · 179 antibiotic prescriptions to 134 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 51 | $50,573 | $992 |
| Myrbetriq | 33 | $31,291 | $948 |
| Ozempic | 27 | $29,421 | $1,090 |
| Tamsulosin | 366 | $6,545 | $18 |
| Potassium Citrate Er | 25 | $3,752 | $150 |
See all 14 drugs
| Gemtesa | 51 | $50,573 | $992 |
| Myrbetriq | 33 | $31,291 | $948 |
| Ozempic | 27 | $29,421 | $1,090 |
| Tamsulosin | 366 | $6,545 | $18 |
| Potassium Citrate Er | 25 | $3,752 | $150 |
| Dutasteride | 65 | $3,026 | $47 |
| Cabergoline | 12 | $1,370 | $114 |
| Finasteride | 41 | $1,033 | $25 |
| Testosterone Cypionate | 11 | $703 | $64 |
| Tadalafil | 14 | $532 | $38 |
| Levofloxacin | 119 | $330 | $3 |
| Sulfamethoxazole-Trimethoprim | 33 | $196 | $6 |
| Oxybutynin Chloride Er | 11 | $158 | $14 |
| Meloxicam | 56 | $123 | $2 |
Year by year
| 2024 | 1,017 | 308 | None | 13% | $158,175 |
| 2023 | 909 | 272 | 2% (21) | None | $134,997 |
| 2022 | 935 | 246 | 2% (17) | 12% | $99,835 |
| 2021 | 1,024 | 244 | 2% (17) | None | $144,295 |
| 2020 | 1,160 | 264 | 1% (16) | 11% | $169,772 |
| 2019 | 1,200 | 254 | 2% (20) | 11% | $161,445 |
| 2018 | 1,227 | 252 | 3% (33) | 21% | $201,933 |
| 2017 | 1,310 | 265 | 2% (31) | 23% | $181,836 |
| 2016 | 1,345 | 249 | 2% (23) | None | $162,788 |
| 2015 | 1,326 | 267 | 3% (35) | None | $141,276 |
| 2014 | 1,270 | 228 | 2% (22) | 27% | $136,506 |
| 2013 | 1,132 | 211 | 2% (27) | 28% | $107,256 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Gemtesa | 59 | $40,078 | $679 |
| Myrbetriq | 35 | $36,613 | $1,046 |
| Tamsulosin | 345 | $8,071 | $23 |
| Dutasteride | 70 | $5,186 | $74 |
| Potassium Citrate Er | 13 | $3,352 | $258 |
| Nitrofurantoin Mono-Macro | 14 | $1,313 | $94 |
| Finasteride | 55 | $1,111 | $20 |
| Oxybutynin Chloride Er | 14 | $918 | $66 |
| Testosterone Cypionate | 14 | $568 | $41 |
| Alfuzosin Hcl Er | 12 | $404 | $34 |
| Levofloxacin | 51 | $395 | $8 |
| Sulfamethoxazole-Trimethoprim | 34 | $285 | $8 |
| Ciprofloxacin | 17 | $237 | $14 |
| Meloxicam | 30 | $108 | $4 |
| Hydrocodone-Acetaminophen | 13 | $91 | $7 |
2022: 17 drugs
| Myrbetriq | 25 | $20,455 | $818 |
| Gemtesa | 17 | $8,455 | $497 |
| Testosterone | 24 | $6,976 | $291 |
| Tamsulosin | 336 | $5,439 | $16 |
| Dutasteride | 60 | $4,518 | $75 |
| Cabergoline | 27 | $3,760 | $139 |
| Solifenacin | 12 | $1,952 | $163 |
| Testosterone Cypionate | 31 | $1,611 | $52 |
| Finasteride | 62 | $1,308 | $21 |
| Oxybutynin Chloride Er | 16 | $897 | $56 |
| Oxybutynin Chloride | 14 | $481 | $34 |
| Levofloxacin | 50 | $396 | $8 |
| Tadalafil | 13 | $341 | $26 |
| Sulfamethoxazole-Trimethoprim | 44 | $262 | $6 |
| Hydrocodone-Acetaminophen | 17 | $136 | $8 |
| Eszopiclone | 11 | $78 | $7 |
| Meloxicam | 22 | $77 | $4 |
2021: 15 drugs
| Testosterone | 92 | $37,634 | $409 |
| Myrbetriq | 47 | $35,769 | $761 |
| Tamsulosin | 316 | $5,771 | $18 |
| Testosterone Cypionate | 83 | $4,718 | $57 |
| Dutasteride | 67 | $3,536 | $53 |
| Cabergoline | 34 | $2,726 | $80 |
| Finasteride | 89 | $2,015 | $23 |
| Solifenacin | 27 | $1,385 | $51 |
| Silodosin | 11 | $1,353 | $123 |
| Tadalafil | 12 | $701 | $58 |
| Oxybutynin Chloride Er | 13 | $486 | $37 |
| Sulfamethoxazole-Trimethoprim | 38 | $307 | $8 |
| Levofloxacin | 40 | $223 | $6 |
| Alfuzosin Hcl Er | 14 | $192 | $14 |
| Hydrocodone-Acetaminophen | 17 | $155 | $9 |
2020: 17 drugs
| Testosterone | 131 | $58,564 | $447 |
| Myrbetriq | 68 | $40,804 | $600 |
| Testosterone Cypionate | 96 | $5,650 | $59 |
| Tamsulosin | 344 | $5,072 | $15 |
| Dutasteride | 78 | $4,007 | $51 |
| Solifenacin | 36 | $3,117 | $87 |
| Cabergoline | 26 | $2,813 | $108 |
| Tadalafil | 25 | $2,539 | $102 |
| Silodosin | 19 | $2,366 | $125 |
| Finasteride | 78 | $1,532 | $20 |
| Tolterodine Tartrate Er | 14 | $1,296 | $93 |
| Oxybutynin Chloride Er | 13 | $580 | $45 |
| Levofloxacin | 54 | $496 | $9 |
| Alfuzosin Hcl Er | 20 | $368 | $18 |
| Sulfamethoxazole-Trimethoprim | 39 | $196 | $5 |
| Hydrocodone-Acetaminophen | 16 | $131 | $8 |
| Meloxicam | 19 | $78 | $4 |
2019: 17 drugs
| Testosterone | 141 | $78,084 | $554 |
| Myrbetriq | 44 | $28,625 | $651 |
| Vesicare | 21 | $11,798 | $562 |
| Tamsulosin | 368 | $6,526 | $18 |
| Tadalafil | 32 | $6,259 | $196 |
| Testosterone Cypionate | 110 | $6,159 | $56 |
| Potassium Citrate Er | 15 | $3,855 | $257 |
| Dutasteride | 63 | $2,639 | $42 |
| Finasteride | 113 | $2,408 | $21 |
| Cabergoline | 18 | $2,116 | $118 |
| Oxybutynin Chloride Er | 34 | $1,766 | $52 |
| Tolterodine Tartrate Er | 17 | $1,412 | $83 |
| Levofloxacin | 45 | $386 | $9 |
| Anastrozole | 12 | $231 | $19 |
| Sulfamethoxazole-Trimethoprim | 35 | $199 | $6 |
| Hydrocodone-Acetaminophen | 20 | $143 | $7 |
| Meloxicam | 16 | $46 | $3 |
2018: 19 drugs
| Testosterone | 109 | $55,174 | $506 |
| Androgel | 23 | $44,676 | $1,942 |
| Cialis | 60 | $26,694 | $445 |
| Myrbetriq | 32 | $18,925 | $591 |
| Tamsulosin | 352 | $7,077 | $20 |
| Potassium Citrate Er | 14 | $6,308 | $451 |
| Testosterone Cypionate | 114 | $5,221 | $46 |
| Tadalafil | 11 | $4,744 | $431 |
| Finasteride | 115 | $2,686 | $23 |
| Cabergoline | 26 | $1,995 | $77 |
| Dutasteride | 57 | $1,764 | $31 |
| Oxybutynin Chloride Er | 36 | $1,202 | $33 |
| Doxazosin Mesylate | 17 | $938 | $55 |
| Pentoxifylline | 16 | $778 | $49 |
| Levofloxacin | 43 | $465 | $11 |
| Hydrocodone-Acetaminophen | 33 | $303 | $9 |
| Sulfamethoxazole-Trimethoprim | 40 | $301 | $8 |
| Sodium Chloride | 11 | $181 | $16 |
| Anastrozole | 12 | $106 | $9 |
2017: 22 drugs
| Cialis | 99 | $39,653 | $401 |
| Androgel | 27 | $35,368 | $1,310 |
| Testosterone | 80 | $34,638 | $433 |
| Vesicare | 17 | $11,100 | $653 |
| Tamsulosin | 388 | $9,394 | $24 |
| Myrbetriq | 15 | $8,729 | $582 |
| Testosterone Cypionate | 72 | $3,630 | $50 |
| Cabergoline | 18 | $3,548 | $197 |
| Dutasteride | 81 | $3,011 | $37 |
| Neomycin-Polymyxin B | 17 | $2,828 | $166 |
| Dutasteride-Tamsulosin | 11 | $2,701 | $246 |
| Finasteride | 131 | $2,403 | $18 |
| Trospium Chloride Er | 11 | $1,567 | $142 |
| Oxybutynin Chloride Er | 13 | $735 | $57 |
| Doxazosin Mesylate | 19 | $687 | $36 |
| Levofloxacin | 62 | $554 | $9 |
| Oxybutynin Chloride | 12 | $548 | $46 |
| Sodium Chloride | 23 | $436 | $19 |
| Pentoxifylline | 12 | $377 | $31 |
| Sulfamethoxazole-Trimethoprim | 55 | $356 | $6 |
| Hydrocodone-Acetaminophen | 31 | $226 | $7 |
| Cephalexin | 14 | $74 | $5 |
2016: 23 drugs
| Cialis | 104 | $31,772 | $305 |
| Androgel | 17 | $26,797 | $1,576 |
| Testosterone | 47 | $24,278 | $517 |
| Vesicare | 30 | $14,613 | $487 |
| Tamsulosin | 464 | $11,022 | $24 |
| Myrbetriq | 24 | $10,315 | $430 |
| Dutasteride-Tamsulosin | 21 | $3,640 | $173 |
| Neomycin-Polymyxin B | 26 | $3,479 | $134 |
| Dutasteride | 60 | $3,056 | $51 |
| Cabergoline | 17 | $2,996 | $176 |
| Rapaflo | 14 | $2,904 | $207 |
| Testosterone Cypionate | 58 | $2,739 | $47 |
| Finasteride | 152 | $2,343 | $15 |
| Oxybutynin Chloride Er | 15 | $1,236 | $82 |
| Nitrofurantoin Mono-Macro | 22 | $1,035 | $47 |
| Sodium Chloride | 25 | $716 | $29 |
| Doxazosin Mesylate | 17 | $535 | $31 |
| Levofloxacin | 41 | $451 | $11 |
| Sulfamethoxazole-Trimethoprim | 40 | $280 | $7 |
| Hydrocodone-Acetaminophen | 22 | $233 | $11 |
| Oxybutynin Chloride | 16 | $201 | $13 |
| Ciprofloxacin | 14 | $139 | $10 |
| Terazosin | 12 | $88 | $7 |
2015: 24 drugs
| Cialis | 107 | $29,002 | $271 |
| Testosterone | 41 | $19,677 | $480 |
| Vesicare | 44 | $16,923 | $385 |
| Tamsulosin | 431 | $12,242 | $28 |
| Avodart | 36 | $7,756 | $215 |
| Jalyn | 39 | $7,283 | $187 |
| Testim | 11 | $6,478 | $589 |
| Testosterone Cypionate | 51 | $3,373 | $66 |
| Neomycin-Polymyxin B | 20 | $2,793 | $140 |
| Oxybutynin Chloride Er | 18 | $1,991 | $111 |
| Finasteride | 142 | $1,937 | $14 |
| Potassium Citrate Er | 11 | $1,659 | $151 |
| Cabergoline | 14 | $1,289 | $92 |
| Doxazosin Mesylate | 25 | $1,022 | $41 |
| Nitrofurantoin Mono-Macro | 17 | $945 | $56 |
| Levofloxacin | 59 | $841 | $14 |
| Sodium Chloride | 21 | $640 | $30 |
| Pentoxifylline | 12 | $508 | $42 |
| Oxybutynin Chloride | 12 | $333 | $28 |
| Hydrocodone-Acetaminophen | 33 | $322 | $10 |
| Alfuzosin Hcl Er | 14 | $285 | $20 |
| Sulfamethoxazole-Trimethoprim | 37 | $274 | $7 |
| Ciprofloxacin | 12 | $141 | $12 |
| Meloxicam | 11 | $37 | $3 |
2014: 23 drugs
| Vesicare | 63 | $20,931 | $332 |
| Androgel | 24 | $18,411 | $767 |
| Testim | 31 | $18,215 | $588 |
| Cialis | 55 | $13,802 | $251 |
| Avodart | 41 | $10,118 | $247 |
| Tamsulosin | 470 | $9,142 | $19 |
| Fortesta | 12 | $8,025 | $669 |
| Jalyn | 37 | $6,350 | $172 |
| Testosterone | 12 | $5,398 | $450 |
| Viagra | 21 | $4,038 | $192 |
| Testosterone Cypionate | 43 | $2,493 | $58 |
| Potassium Citrate Er | 13 | $2,477 | $191 |
| Finasteride | 127 | $1,978 | $16 |
| Oxybutynin Chloride Er | 19 | $1,362 | $72 |
| Nitrofurantoin Mono-Macro | 21 | $1,284 | $61 |
| Neomycin-Polymyxin B | 11 | $1,265 | $115 |
| Pentoxifylline | 39 | $992 | $25 |
| Levofloxacin | 51 | $963 | $19 |
| Doxazosin Mesylate | 22 | $725 | $33 |
| Sodium Chloride | 11 | $189 | $17 |
| Sulfamethoxazole-Trimethoprim | 26 | $173 | $7 |
| Hydrocodone-Acetaminophen | 20 | $173 | $9 |
| Ciprofloxacin | 11 | $53 | $5 |
2013: 23 drugs
| Vesicare | 61 | $16,415 | $269 |
| Fortesta | 26 | $15,399 | $592 |
| Testim | 29 | $13,708 | $473 |
| Avodart | 50 | $9,651 | $193 |
| Androgel | 11 | $7,971 | $725 |
| Tamsulosin | 401 | $7,694 | $19 |
| Jalyn | 38 | $6,204 | $163 |
| Cialis | 34 | $5,344 | $157 |
| Cabergoline | 16 | $2,761 | $173 |
| Testosterone Cypionate | 49 | $2,558 | $52 |
| Finasteride | 64 | $1,760 | $27 |
| Oxybutynin Chloride Er | 28 | $1,729 | $62 |
| Potassium Citrate | 15 | $1,663 | $111 |
| Neomycin-Polymyxin B | 14 | $1,659 | $118 |
| Staxyn | 11 | $1,073 | $98 |
| Nitrofurantoin Mono-Macro | 15 | $981 | $65 |
| Pentoxifylline | 27 | $898 | $33 |
| Levofloxacin | 44 | $542 | $12 |
| Doxazosin Mesylate | 30 | $481 | $16 |
| Oxybutynin Chloride | 14 | $371 | $26 |
| Sulfamethoxazole-Trimethoprim | 26 | $217 | $8 |
| Sodium Chloride | 16 | $164 | $10 |
| Hydrocodone-Acetaminophen | 20 | $125 | $6 |
Money from drug and device companies
$4,991 in 2025
| 2025 | 16 | 90 | $750 | $4,991 |
| 2024 | 14 | 81 | $8,125 | $21,212 |
| 2023 | 23 | 141 | $23,648 | $29,272 |
| 2022 | 18 | 158 | $54,885 | $65,452 |
| 2021 | 18 | 94 | $35,840 | $79,800 |
| 2020 | 13 | 52 | $31,300 | $44,335 |
| 2019 | 14 | 173 | $125,100 | $152,054 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
PROCEPT BioRobotics Corporation
$107,618
Held by this doctor · 2020, 2019 · Common Stock; Preferred Stock and Warrants To Purchase Preferred Stock · amount invested $24,999
Published ownership or investment in a drug or device company. This is not proof that care is biased.
A payment is not proof that care is biased.
| Boston Scientific | General - Erectile Dysfunction | $2,185 | 6 payments
|
| Coloplast | Titan | $1,351 | 10 payments
|
| Antares Pharma | Xyosted | $433 | 40 payments
|
| Abbvie | Botox | $239 | 9 payments
|
| Sumitomo Pharma America | Gemtesa | $212 | 9 payments
|
| Valencia Technologies | Ecoin Device Kit | $185 | 2 payments
|
See all 90 published payments
| Abbvie | Meals · 2025-12-19 | Botox | $28 |
| Antares Pharma | Meals · 2025-12-17 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-12-17 | Xyosted | $21 |
| Boston Scientific | Meals · 2025-12-11 | Eluvia | $54 |
| Accord Healthcare | Meals · 2025-12-11 | Camcevi | $19 |
| Sumitomo Pharma America | Meals · 2025-12-04 | Gemtesa | $39 |
| Abbvie | Meals · 2025-12-04 | Lupron Depot | $18 |
| Antares Pharma | Meals · 2025-12-03 | Xyosted | $23 |
| Antares Pharma | Meals · 2025-12-03 | Xyosted | $1 |
| Coloplast | Meals · 2025-12-02 | Titan | $172 |
| Novartis Pharmaceuticals | Meals · 2025-11-21 | Pluvicto | $34 |
| Antares Pharma | Meals · 2025-11-19 | Xyosted | $1 |
| Antares Pharma | Meals · 2025-11-19 | Xyosted | $20 |
| Coloplast | Meals · 2025-11-17 | Titan | $34 |
| Sumitomo Pharma America | Meals · 2025-11-13 | Gemtesa | $6 |
| Abbvie | Meals · 2025-11-13 | Botox | $23 |
| Abbvie | Meals · 2025-11-11 | Lupron Depot | $25 |
| Coloplast | Meals · 2025-10-30 | Titan | $140 |
| Pfizer | Meals · 2025-10-30 | Xtandi | $31 |
| Coloplast | Meals · 2025-10-29 | Titan | $24 |
| Antares Pharma | Meals · 2025-10-29 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-10-29 | Xyosted | $19 |
| Antares Pharma | Meals · 2025-10-15 | Xyosted | $1 |
| Antares Pharma | Meals · 2025-10-15 | Xyosted | $20 |
| Coloplast | Meals · 2025-10-10 | Altis | $40 |
| Antares Pharma | Meals · 2025-09-24 | Xyosted | $21 |
| Dendreon Pharmaceuticals | Meals · 2025-09-12 | Provenge | $26 |
| Antares Pharma | Meals · 2025-09-10 | Xyosted | $20 |
| Antares Pharma | Meals · 2025-09-10 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-08-27 | Xyosted | $19 |
| Antares Pharma | Meals · 2025-08-27 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-08-13 | Xyosted | $14 |
| Antares Pharma | Meals · 2025-08-13 | Xyosted | $3 |
| Astellas Pharma US | Meals · 2025-08-12 | Xtandi | $26 |
| Verity Pharmaceuticals | Meals · 2025-08-11 | Tlando | $20 |
| Sumitomo Pharma America | Meals · 2025-08-06 | Orgovyx | $24 |
| Dendreon Pharmaceuticals | Meals · 2025-08-05 | Provenge | $16 |
| Boston Scientific | Meals · 2025-08-01 | General - Erectile Dysfunction | $9 |
| Abbvie | Meals · 2025-08-01 | Botox | $28 |
| Coloplast | Meals · 2025-08-01 | Titan | $144 |
| Boston Scientific | Grant · 2025-07-31 | General - Erectile Dysfunction | $2,000 |
| Antares Pharma | Meals · 2025-07-30 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-07-30 | Xyosted | $17 |
| Progenics Pharmaceuticals | Meals · 2025-07-10 | Pylarify | $22 |
| Antares Pharma | Meals · 2025-07-09 | Xyosted | $17 |
| Sumitomo Pharma America | Meals · 2025-07-08 | Orgovyx | $26 |
| Sumitomo Pharma America | Meals · 2025-06-20 | Gemtesa | $29 |
| Antares Pharma | Meals · 2025-06-04 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-06-04 | Xyosted | $18 |
| Sumitomo Pharma America | Meals · 2025-05-30 | Orgovyx | $23 |
| Progenics Pharmaceuticals | Meals · 2025-05-29 | Pylarify | $24 |
| Boston Scientific | Meals · 2025-05-27 | General - Vascular Intervention | $60 |
| Sumitomo Pharma America | Meals · 2025-05-21 | Gemtesa | $21 |
| Abbvie | Meals · 2025-05-21 | Botox | $27 |
| Antares Pharma | Meals · 2025-05-21 | Xyosted | $3 |
| Antares Pharma | Meals · 2025-05-21 | Xyosted | $15 |
| Sumitomo Pharma America | Meals · 2025-05-08 | Gemtesa | $39 |
| Astellas Pharma US | Meals · 2025-05-08 | Xtandi | $24 |
| Antares Pharma | Meals · 2025-05-07 | Xyosted | $19 |
| Antares Pharma | Meals · 2025-05-07 | Xyosted | $2 |
| Valencia Technologies | Meals · 2025-04-28 | Ecoin Device Kit | $44 |
| Abbvie | Meals · 2025-04-25 | Botox | $29 |
| Valencia Technologies | Meals · 2025-04-25 | Ecoin Device Kit | $141 |
| Antares Pharma | Meals · 2025-04-23 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-04-23 | Xyosted | $17 |
| Merck Sharp & Dohme | Meals · 2025-04-23 | Keytruda | $33 |
| Boston Scientific | Meals · 2025-04-21 | Axonics | $26 |
| Coloplast | Consulting · 2025-04-10 | Titan | $500 |
| Antares Pharma | Meals · 2025-04-09 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-04-09 | Xyosted | $16 |
| Endo USA | Meals · 2025-04-02 | Xiaflex | $18 |
| Coloplast | Meals · 2025-03-31 | Titan | $4 |
| Coloplast | Meals · 2025-03-31 | Titan | $44 |
| Antares Pharma | Meals · 2025-03-26 | Xyosted | $16 |
| Antares Pharma | Meals · 2025-03-26 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-03-12 | Xyosted | $16 |
| Sumitomo Pharma America | Education · 2025-03-06 | Gemtesa | $5 |
| Abbvie | Meals · 2025-02-28 | Botox | $31 |
| Coloplast | Consulting · 2025-02-28 | Titan | $250 |
| Antares Pharma | Meals · 2025-02-19 | Xyosted | $15 |
| Antares Pharma | Meals · 2025-02-19 | Xyosted | $2 |
| Boston Scientific | Meals · 2025-02-13 | Axonics | $36 |
| Antares Pharma | Meals · 2025-02-05 | Xyosted | $19 |
| Antares Pharma | Meals · 2025-01-22 | Xyosted | $18 |
| Antares Pharma | Meals · 2025-01-22 | Xyosted | $2 |
| TriSalus Life Sciences | Meals · 2025-01-17 | Trinav Infusion System | $69 |
| Endo USA | Meals · 2025-01-15 | Aveed | $24 |
| Abbvie | Meals · 2025-01-10 | Botox | $32 |
| Antares Pharma | Meals · 2025-01-08 | Xyosted | $2 |
| Antares Pharma | Meals · 2025-01-08 | Xyosted | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $21,212
| Coloplast | Titan | $18,017 | 16 payments
|
| Noah Medical | Galaxy | $1,000 | 1 payment
|
| Axonics | Axonics | $693 | 8 payments
|
| Antares Pharma | Xyosted | $428 | 30 payments
|
| Endo Pharmaceuticals | Xiaflex | $325 | 5 payments
|
| Medtronic | Interstim | $211 | 3 payments
|
| Sumitomo Pharma America | Gemtesa | $196 | 7 payments
|
| Astellas Pharma US | Myrbetriq | $89 | 3 payments
|
| Innovation Technologies | Irrisept | $84 | 1 payment
|
| Boston Scientific | Angiojet Ultra 5000a | $49 | 1 payment
|
| Endo USA | Xiaflex | $42 | 2 payments
|
| Abbvie | Lupron Depot | $39 | 2 payments
|
| Pfizer | Xtandi | $21 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $17 | 1 payment
|
2023: $29,272
| Coloplast | Titan | $22,148 | 26 payments
|
| Innovation Technologies | Irrisept | $2,670 | 3 payments
|
| Axonics | Axonics | $1,762 | 16 payments
|
| Sumitomo Pharma America | Gemtesa | $613 | 20 payments
|
| Antares Pharma | Nocdurna | $354 | 13 payments
|
| Richard Wolf Medical Instruments | None | $350 | 1 payment
|
| Supernus Pharmaceuticals | Xyosted | $295 | 22 payments
|
| Astellas Pharma US | Myrbetriq | $248 | 10 payments
|
| Agiliti Surgical | Sonablate | $151 | 2 payments
|
| Endo Pharmaceuticals | Aveed | $150 | 8 payments
|
| Edap Technomed | None | $125 | 1 payment
|
| Amgen | Xgeva | $59 | 2 payments
|
| Pfizer | Xtandi | $55 | 4 payments
|
| Dendreon Pharmaceuticals | Provenge | $48 | 1 payment
|
| Abbvie | Botox | $40 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $39 | 2 payments
|
| Biotissue Holdings | Neox | $38 | 2 payments
|
| Tolmar | Eligard | $23 | 1 payment
|
| Accord Healthcare | Camcevi | $23 | 1 payment
|
| Myriad Genetic Laboratories | Myrisk | $23 | 1 payment
|
| Janssen Biotech | Erleada | $21 | 1 payment
|
| Medtronic | Interstim | $20 | 1 payment
|
| UroGen Pharma | None | $15 | 1 payment
|
2022: $65,452
| Coloplast | Titan | $58,927 | 70 payments
|
| Innovation Technologies | Irrisept | $4,292 | 5 payments
|
| Urovant Sciences | Gemtesa | $536 | 22 payments
|
| Antares Pharma | Nocdurna | $525 | 20 payments
|
| Endo Pharmaceuticals | Xiaflex | $461 | 15 payments
|
| Dendreon Pharmaceuticals | Provenge | $133 | 4 payments
|
| Abbvie | Lupron Depot | $124 | 5 payments
|
| Astellas Pharma US | Myrbetriq | $120 | 6 payments
|
| Rigicon | Rigi10 Malleable Penile Prosthesis | $107 | 1 payment
|
| Organogenesis | Puraply | $43 | 1 payment
|
| Teleflex | Urolift | $37 | 1 payment
|
| Janssen Biotech | Erleada | $36 | 2 payments
|
| Olympus America | Itind System | $23 | 1 payment
|
| Hollister | Infyna Chic | $22 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $20 | 1 payment
|
| Pfizer | Xtandi | $18 | 1 payment
|
| SRS Medical Systems | Urocuff | $15 | 1 payment
|
| UroGen Pharma | Jelmyto | $12 | 1 payment
|
2021: $79,800
| Boston Scientific | Advance | $39,749 | 15 payments
|
| Coloplast | Titan | $38,867 | 41 payments
|
| Endo Pharmaceuticals | Xiaflex | $538 | 6 payments
|
| Antares Pharma | Xyosted | $200 | 13 payments
|
| Innovation Technologies | Irrisept | $110 | 1 payment
|
| AbbVie | Lupron Depot | $76 | 3 payments
|
| Urovant Sciences | Gemtesa | $65 | 3 payments
|
| Hollister | Vapro | $37 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lynparza | $23 | 1 payment
|
| Myriad Genetic Laboratories | Prolaris | $19 | 1 payment
|
| Janssen Biotech | Erleada | $16 | 1 payment
|
| Allergan | Botox | $16 | 1 payment
|
| Clarus Therapeutics | Jatenzo | $16 | 1 payment
|
| Photocure | Cysview | $15 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $15 | 1 payment
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $14 | 1 payment
|
| Axonics | Axonics R-Snm System | $12 | 1 payment
|
| Laborie Medical Technologies | None | $12 | 1 payment
|
2020: $44,335
| Boston Scientific | Advance | $34,344 | 12 payments
|
| Coloplast | Titan | $9,242 | 7 payments
|
| Endo Pharmaceuticals | Xiaflex | $195 | 10 payments
|
| Antares Pharma | Otrexup | $154 | 8 payments
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $105 | 2 payments
|
| Contura | Bulkamid | $83 | 1 payment
|
| Pfizer | Xtandi | $53 | 3 payments
|
| Janssen Biotech | Erleada | $51 | 3 payments
|
| Astellas Pharma US | Vesicare | $39 | 2 payments
|
| Hollister | Vapro | $24 | 1 payment
|
| Amgen | Xgeva | $21 | 1 payment
|
| Laborie Medical Technologies | None | $13 | 1 payment
|
| 180 Medical | Speedicath | $11 | 1 payment
|
2019: $152,054
| Boston Scientific | Ams | $138,037 | 102 payments
|
| Coloplast | Titan | $12,844 | 11 payments
|
| Endo Pharmaceuticals | Xiaflex | $305 | 13 payments
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $279 | 4 payments
|
| Janssen Biotech | Erleada | $128 | 12 payments
|
| Astellas Pharma US | Xtandi | $111 | 13 payments
|
| Pfizer | Xtandi | $96 | 6 payments
|
| Amgen | Xgeva | $63 | 2 payments
|
| Antares Pharma | Xyosted | $44 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Nubeqa | $40 | 2 payments
|
| Ferring Pharmaceuticals | Firmagon | $39 | 2 payments
|
| Dendreon Pharmaceuticals | Provenge | $24 | 1 payment
|
| TherapeuticsMD | Imvexxy | $24 | 1 payment
|
| 180 Medical | Gentlecath | $18 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Innovation Technologies Inc · Irrisept Vs. Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement · 2024 | This clinician | $7,500 |
| Boston Scientific Corporation · Moabstdy · 2025 | Their institution | $5,703 |
| Boston Scientific Corporation · Propper · 2019 | Their institution | $1,087 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1851349609
- Licence
- CA A73115California A73115: Current · expires 2028-03-31
- Trained
- University of Vermont College of Medicine, 1999
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 2495 Hospital Dr Ste 425, Mountain View, CA, 94040
- NPI first listed
- 2006-05-04
- NPI last updated
- 2025-12-29
- NPI record certified
- 2025-12-29
This is when the NPI record was last certified, not a medical board exam.